Sun Pharmaceutical Industries

Launch date

1983

Employees

Market cap

Enterprise valuation

CAD80.0b (Public information from Sep 2024)

Mumbai Maharashtra (HQ)

http://sunpharma.com

https://twitter.com/sunpharma_live https://www.facebook.com/sunpharmalive https://www.linkedin.com/company/sun-pharma

Revenues, earnings & profits over time

INR	2021	2022	2023	2024	2025	2026	2027
Revenues	331.4b	384.3b	432.8b	477.6b	531.5b	590.0b	631.5b
% growth	3 %	16 %	13 %	10 %	11 %	11 %	7 %
EBITDA	90.5b	116.0b	122.8b	142.9b	146.4b	167.0b	181.3b
% EBITDA margin	27 %	30 %	28 %	30 %	28 %	28 %	29 %
Profit	29.0b	32.7b	84.7b	95.8b	113.1b	130.7b	145.6b
% profit margin	9 %	9 %	20 %	20 %	21 %	22 %	23 %
EV / revenue	4.1x	5.4x	5.2x	7.8x	7.9x	7.0x	6.5x
EV / EBITDA	15.1x	17.9x	18.5x	26.1x	28.6x	24.7x	22.4x

Date	Investors	Amount	Round
Jan 1999	N/A	N/A	IPO
Dec 2015	Nostrum Laboratories	N/A	Acquisition
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

By Country

United States 8 India 6 Israel 2 Russia 1 Japan 1

By Industry

By Round

ACQUISITION 8 LATE VC 4 EARLY VC 3 POST IPO SECONDARY 1 SERIES B 1 SERIES E 1

DUSA Pharmaceuticals

ACQUISITION by Sun Pharmaceutical Industries Nov 2012

ACQUISITION by Sun Pharmaceutical Industries Sep 2015

Concert Pharmaceuticals

ACQUISITION by Sun Pharmaceutical Industries Jan 2023

Ranbaxy Laboratories

ACQUISITION by Sun Pharmaceutical Industries Apr 2014

ScPharmaceuticals

exited

Lyndra Therapeutics (Formerly Lyndra)

Krystal Biotech

exited

ACQUISITION by Sun Pharmaceutical Industries Nov 2016